ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia

NCT06364774 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Beta-Thalassemia

Interventions

BIOLOGICAL: ALS20

Sponsor

Children's Hospital of Philadelphia